This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview

This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

Optimizing Cardiovascular Risk Reduction in High-Risk Patients Through Lipid Management

Optimizing Cardiovascular Risk Reduction in High-Risk Patients Through Lipid Management

Format

Webcast

Time to Complete

2 hours

Released

September 30, 2017

Expires

September 30, 2018
Add to Queue


Maximum Credits

2.00 / AMA PRA Category 1 CreditsTM
2.00 / CNE Contact Hours
2.00 / CE for Pharmacists (0.20 CEUs)
2.00 / CPEU for Registered Dietitians

Accredited Provider

Provided by The National Lipid Association and Annenberg Center for Health Sciences at Eisenhower.

Commercial Supporter

This activity is supported by an educational funding donation provided by Amgen.

Program Description

In this video webcast of a satellite symposium held during the National Lipid Association’s Fall Clinical Lipid Update 2017, Peter Howard Jones, MD, and Joseph J. Saseen, PharmD, provide their insights into the evolving lipid management of patients at high risk for cardiovascular events. To better facilitate the integration of recent data into real-world clinical practice, Drs. Jones and Saseen discuss 4 case scenarios of patients at different levels of cardiovascular risk. There is no fee for this activity.

Intended Audience

This activity is designed to meet the needs of physicians, physician assistants, pharmacists, registered nurses, nurse practitioners, advanced practice registered nurses, and registered dietitians with an interest in clinical lipidology.

Educational Objectives

At the conclusion of this activity, participants should be better able to:

  • Discuss real-world implications of new data on proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors
  • Explain the effect of PCSK9 inhibition in specific clinical scenarios (eg, diabetes, familial hypercholesterolemia, statin intolerance)
  • Identify patients who may benefit from the use of PCSK9 inhibitors―either as monotherapy or in combination with a statin―in order to optimally reduce the risk for atherosclerotic cardiovascular disease (ASCVD)
  • Evaluate lipid management treatment plans to reduce ASCVD risk in patients at particularly high risk

Conflict Of Interest Disclosure Policy

It is the policy of NLA to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflict of interest is resolved by NLA prior to accreditation of the activity. NLA planners and reviewers have no relevant financial relationships to disclose.

Faculty

Peter Howard Jones, MD, FACP, FNLA
Medical Director
Weight Management Center
Houston Methodist Hospital
Associate Professor of Medicine
Center for Cardiovascular Disease Prevention
Houston Methodist DeBakey Heart and Vascular Center
Baylor College of Medicine
Houston, Texas

Dr. Jones discloses the following:
Consultant: Amgen, Merck & Co, Inc, Sanofi/Regeneron

Joseph J. Saseen, PharmD, CLS, FNLA
Professor and Vice Chair
Department of Clinical Pharmacy
Professor, Department of Family Medicine
University of Colorado Anschutz Medical Campus
Aurora, Colorado

Dr. Saseen has nothing to disclose.

Accredited Provider Disclosures

Annenberg Center for Health Sciences at Eisenhower has nothing to disclose.
National Lipid Association has nothing to disclose.

Publishing Staff Disclosures

Dave Dixon has nothing to disclose.

Credit

2.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement


In support of improving patient care, this activity has been planned and implemented by The National Lipid Association and Annenberg Center for Health Sciences at Eisenhower. The National Lipid Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation Statement

The National Lipid Association designates this enduring internet activity for a maximum of 2.00 AMA PRA Category 1 CreditsTM .   Physicians should claim only credit commensurate with the extent of their participation in this activity.

Physician Assistants
NCCPA accepts AMA PRA Category 1 CreditsTM  from organizations accredited by the ACCME.

Credit

2.00

Type

CNE Contact Hour(s)

Accreditation Statement


In support of improving patient care, this activity has been planned and implemented by The National Lipid Association and Annenberg Center for Health Sciences at Eisenhower. The National Lipid Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation Statement

The maximum number of hours awarded for this CE activity is 2.00 contact hours.

Credit

2.00

Type

CE for Pharmacists

Accreditation Statement


In support of improving patient care, this activity has been planned and implemented by The National Lipid Association and Annenberg Center for Health Sciences at Eisenhower. The National Lipid Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation Statement

Universal Activity Number 0624-9999-17-055-H01-P (Knowledge) This Activity has been approved for 2.00 contact hour(s) (0.20 CEUs) of the Accreditation Council for Pharmacy Education

Credit

2.00

Type

CPEU Credit

Accreditation Statement


In support of improving patient care, this activity has been planned and implemented by The National Lipid Association and Annenberg Center for Health Sciences at Eisenhower. The National Lipid Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation Statement

The National Lipid Association is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 2.0 continuing professional education units (CPEUs) for completion of this program/ materials. CDR Accredited Provider #NL002.

Disclosure of Unlabeled Use

This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

This course is designed solely to provide the health care professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the health care professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. The NLA specifically disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through reader’s misunderstanding of content.

Instructions

To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 CreditsTM, participants must receive a minimum score of 70% on the post-test.

If you have questions about this CME activity, please contact the NLA at cme@lipid.org. Please claim credit by September 30, 2018.

For pharmacists: Upon receipt of the completed activity evaluation form, transcript information will be available at www.mycpemonitor.net within 4 weeks.

Please note: The content of this activity is housed on the website of our educational partner, Annenberg Center for Health Sciences at Eisenhower, and requires you to leave myCME and register on the Annenberg website.

Your certificate will be saved on the Annenberg website only and cannot be accessed in your myCME CME History. Please go to https://education.annenberg.net and sign in to access your certificate in the future.

Contact Information

For help or questions about this Internet activity, please contact Annenberg Continuing Education:
ce@annenberg.net
Annenberg Center for Health Sciences
39000 Bob Hope Drive
Dinah Shore Building
Rancho Mirage, CA 92270
Phone: 760-773-4500
Fax: 760-773-4513
8 AM – 5 PM, Pacific Time, Monday – Friday

Privacy Policy

Annenberg Center for Health Sciences respects your privacy. We don’t share information you give us, or have the need to share this information in the normal course of providing the services and information you may request. If there should be a need or request to share this information, we will do so only with your explicit permission. See Privacy Statement and other information at http://www.annenberg.net/privacy-policy/

NLA’s Privacy Statement

myCME privacy policy
Add to Queue